Doxycycline Hyclate Contract Award SPE2D2-25-D-0015

The contract for Doxycycline Hyclate under award number SPE2D2-25-D-0015 has been extended for the period from July 2, 2026, through July 1, 2027, with all other terms and conditions remaining unchanged. This action formalizes the continuation of the existing agreement without modifications to pricing, delivery schedules, or performance requirements. The award is managed by the Department of Defense through DLA Troop Support, with the primary office located in Philadelphia, Pennsylvania, and the product to be delivered to Laurelton, New York, under the NAICS code 325412 for pharmaceutical preparation manufacturing. Point of contact for inquiries is Courtney Hunter, reachable via email or phone, with Jason Wray designated as the secondary contact. The contract remains unmodified in all aspects except for the revised performance period, and no set-aside provisions apply to this award.